Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Type 2 diabetes patients with first OAD (Sulfonylurea \[SU\] or Metformin) failure
Patients who are insulin naive (unless it was used for gestational diabetes or if insulin therapy was less than 1 week)
Serum creatinine ≤ 1.5mg/dL
BMI: 21-41 kg/m²
7.5%\< A1c \<11%
Fasting plasma glucose \> 7.5mmol/L
On diet and exercise therapy and stable OAD treatment (SU or metformin \> ½ maximal dose)for more than 1 month prior to enrolment
Women not of childbearing potential (sterilization procedure done or menopausal \> 2 years), or if of childbearing potential, agree to take reliable contraceptive measures during the study
Able and willing to monitor blood glucose
Able and willing to perform 7 point blood glucose self monitoring at baseline, 12 week and 24 week
Understand that there is a 50% chance of being randomized to the insulin treatment arm and is willing to self inject insulin
You may not be if
Type 1 diabetes
Acute complication of diabetes, such as diabetic ketoacidosis and hyperosmolar coma
Pregnancy, breast-feeding
People who work night shifts
Hypersensitivity to investigational drugs or its additives, or intolerability to metformin
Need for use of medications prohibited by the protocol during the study for treatment purpose
Significant diseases in cardiovascular, liver, nerve, endocrine or other systems, unable to complete the study or difficult to be used in study analysis
Drugs or alcohol abuse
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.